Interestingly, expression of HDAC6 was found to be increased in various kidney conditions including fibrotic, ADPKD and CKD models, and HDAC6 inhibitors showed a positive effect on disease evolution (Ke et al., 2018). This evidence concerns the gene HDAC6 and chronic kidney disease.